223Ra-dichloride SPECT and planar quantitative images for targeted alpha-emitting therapy of bone metastases.

被引：0
|
作者：
Benabdallah, Nadia [3 ]
Bernardini, Michela [1 ]
de Labriolle-Vaylet, Claire [2 ]
Franck, Didier [3 ]
Desbree, Aurelie [3 ]
机构：
[1] Hapital Europaen George Pompidou, Paris, France
[2] Hapital Trousseau, Paris, France
[3] IRSN, Fontenay Aux Roses, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2016年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1019
引用
收藏
页数：2
相关论文
共 50 条
  • [31] "Overall PET Response" index based on 18F-FCH PET/CT semiquantitative parameters: a useful method to evaluate 223Ra-dichloride therapy efficacy in mCRPC patients with bone metastases
    Ferrari, C.
    Asabella, A. Niccoli
    Lavelli, V.
    Nappi, A. G.
    Sisto, S.
    Sigrisi, G.
    Fanelli, M.
    Rubini, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S526 - S526
  • [32] Correlation between Bone Lesion Dosimetry and Pain Outcome in Patients (pts) with Castration-Resistant Prostate Cancer (CRPC) undergoing 223Ra-dichloride Therapy
    Follacchio, G. A.
    Frantellizzi, V.
    Pacilio, M.
    Cassano, B.
    Pani, R.
    Pellegrini, R.
    De Vincentis, G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S215 - S215
  • [33] Pain analyses from the phase III randomized ALSYMPCA study with radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients with bone metastases.
    Nilsson, Sten
    Sartor, A. Oliver
    Bruland, Oyvind S.
    Fang, Fang
    Aksnes, Anne-Kirsti
    Parker, Chris
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [34] Radium-223 dichloride bone-targeted alpha particle therapy for hormone-refractory breast cancer metastatic to bone
    Takalkar A.
    Adams S.
    Subbiah V.
    Experimental Hematology & Oncology, 3 (1)
  • [35] DIRECT BONE TARGETED THERAPY USING ALPHA PARTICLE-RADIUM223 FOR OSTEOBLASTIC METASTASES IN OSTEOSARCOMA PATIENTS
    Subbiah, V.
    McAleer, M.
    Rohren, E.
    Huh, W.
    Mahajan, A.
    Anderson, P.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 86 - 86
  • [36] Ra-223 alpha-Therapy in Patients with Bone Metastases from Castration-resistant Prostate Cancer
    Jessome, Rebecca
    JOURNAL OF MEDICAL IMAGING AND RADIATION SCIENCES, 2015, 46 (02) : 156 - 161
  • [37] Nano-hydroxyapatite radiolabeled with radium dichloride [223Ra] RaCl2 for bone cancer targeted alpha therapy: In vitro assay and radiation effect on the nanostructure
    Gemini-Piperni, Sara
    Ricci-Junior, Eduardo
    Ilem-Ozdemir, Derya
    Batista, Beatriz da Silva
    Alencar, Luciana Magalhaes Rabelo
    Rossi, Alexandre Malta
    Santos-Oliveira, Ralph
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2023, 223
  • [38] Delivered Activity Accuracy of Radium 223 Dichloride Injections, When Being Administrated for Castration Resistant Prostate Cancer, Symptomatic Bone Metastases. The Impact of Residual Activity in the Spent Syringe and Dispensing Accuracy of Ra 223
    Jennings, G.
    MEDICAL PHYSICS, 2016, 43 (06) : 3474 - 3474
  • [39] A phase 2 randomized, double-blind, placebo-controlled trial of endocrine therapy ± radium-223 dichloride (Ra-223) in HER2- hormone receptor+ breast cancer patients with bone metastases.
    Coleman, Robert E.
    Li, Rui
    Sawhney, Amrita G.
    Petrenciuc, Oana
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [40] Bone scan activity concentration in prostate cancer bone metastases predicts response to Ra-223Cl2-therapy: a SPECT/CT study
    Fiz, F.
    Weissinger, M.
    Dittman, H.
    Campi, C.
    Morbelli, S.
    Piana, M.
    Sambuceti, G.
    La Fougere, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S534 - S535
12345